WHERE
  CANCER
SURVIVAL
  IS
  MAXIMISED

WHERE
  CANCER
SURVIVAL
  IS
  MAXIMISED

Over our lifetimes, one in two of us will be affected by cancer – treatments can be gruelling and, sadly, often ineffective.
Help us to tackle this devastating disease.

1 in 2

One in two people will be diagnosed with cancer in their lifetime. In the UK, half of all people born today are expected to develop some form of cancer in their lives.

420,000

420,000 people are diagnosed with cancer each year in the UK alone. On average, someone is diagnosed with cancer every 90 seconds.

10M

Cancer is one of the world’s leading causes of death, with around 10 million deaths globally each year. That’s nearly one in six people.

Over our lifetimes, one in two of us will be affected by cancer – treatments can be gruelling and, sadly, often ineffective.

Help us to tackle this devastating disease.

1 in 2

One in two people will be diagnosed with cancer in their lifetime. In the UK, half of all people born today are expected to develop some form of cancer in their lives.

420,000

420,000 people are diagnosed with cancer each year in the UK alone. On average, someone is diagnosed with cancer every 90 seconds.

10M

Cancer is one of the world’s leading causes of death, with around 10 million deaths globally each year. That’s nearly one in six people.

SOUTHAMPTON IS AT THE FOREFRONT OF CANCER RESEARCH

For more than 40 years, scientists at the University of Southampton have been at the very forefront of cancer research. Our Centre for Cancer Immunology, the UK’s first centre dedicated to cancer immunology, is offering hope for patients when there was none.

We are transforming cancer care by combining pioneering immune-based treatments with earlier diagnosis and smarter, more personalised care. Our clinical trials are already showing remarkable success in cancers such as lymphoma, melanoma, head and neck.

We are using AI and machine learning to analyse clinical data, helping us better predict how patients will respond to treatments like chemotherapy and surgery and tailor treatment plans to each individual.

At Southampton, we have the skills and expertise to save and improve the lives of people suffering with cancer. But we need your support to do it faster.

Artist impression of the Institute for Medical Innovation, next door to the Centre for Cancer Immunology.
Artist impression of the Institute for Medical Innovation, next door to the Centre for Cancer Immunology

SOUTHAMPTON IS AT THE FOREFRONT OF CANCER RESEARCH

For more than 40 years, scientists at the University of Southampton have been at the very forefront of cancer research. Our Centre for Cancer Immunology, the UK’s first centre dedicated to cancer immunology, is offering hope for patients when there was none.

We are transforming cancer care by combining pioneering immune-based treatments with earlier diagnosis and smarter, more personalised care. Our clinical trials are already showing remarkable success in cancers such as lymphoma, melanoma, head and neck.

We are using AI and machine learning to analyse clinical data, helping us better predict how patients will respond to treatments like chemotherapy and surgery and tailor treatment plans to each individual.

At Southampton, we have the skills and expertise to save and improve the lives of people suffering with cancer. But we need your support to do it faster.

Artist impression of the Institute for Medical Innovation, next door to the Centre for Cancer Immunology.
Artist impression of the Institute for Medical Innovation, next door to the Centre for Cancer Immunology
An adult lifts a small child into the air outdoors, with tall green plants and a bright sky in the background.

the imi will advance cancer research

With your support, the Institute for Medical Innovation (IMI) will enable us to accelerate the pace of cancer research. The IMI will be located right beside the Centre for Cancer Immunology, allowing researchers to benefit from both facilities.

The IMI will help us:

Detect cancers at an earlier stage and with greater accuracy – working with biomathematicians and computer scientists to analyse scan data and identify new biomarkers that could signal the beginning of cancer.

Understand cancer at a deeper level using advanced imaging techniques – cutting-edge facilities will allow us to look at tumour cells under a range of lenses, giving us invaluable insights into how the disease develops, and can be treated.

Advance precision medicine – identifying rare cancers that might benefit from targeted treatments and developing personalised treatment plans based on the genetic profiles of patients.  

the imi will advance cancer research

With your support, the Institute for Medical Innovation (IMI) will enable us to accelerate the pace of cancer research. The IMI will be located right beside the Centre for Cancer Immunology, allowing researchers to benefit from both facilities.

The IMI will help us:

Detect cancers at an earlier stage and with greater accuracy – working with biomathematicians and computer scientists to analyse scan data and identify new biomarkers that could signal the beginning of cancer.

Understand cancer at a deeper level using advanced imaging techniques – cutting-edge facilities will allow us to look at tumour cells under a range of lenses, giving us invaluable insights into how the disease develops, and can be treated.

Advance precision medicine – identifying rare cancers that might benefit from targeted treatments and developing personalised treatment plans based on the genetic profiles of patients.  

An adult lifts a small child into the air outdoors, with tall green plants and a bright sky in the background.

Allan’s Story

When former royal protection officer Allan Peters was told his advanced B-cell lymphoma was terminal, he began planning his funeral. Just over a year later, he was cancer-free after receiving pioneering CAR T-cell therapy at University Hospital Southampton, a breakthrough treatment he describes as nothing short of a miracle.

Leading the fight against cancer

Some of the great minds leading cancer research at the IMI. Learn more about some of the brilliant people who will work together in the IMI to help fight against cancer.

Leading the fight against cancer

Some of the great minds leading cancer research at the IMI. Learn more about some of the brilliant people who will work together in the IMI to help fight against cancer.

Professor Diana Eccles
Dean of Medicine and Professor of Cancer Genetics

Diana is a world-renowned expert on clinical genetics. Her research focuses on cancer predisposition and management of hereditary breast cancer.

Professor Peter Johnson, CBE
Professor of Medical Oncology

Peter holds prestigious titles including National Clinical Director for Cancer and Director of the Southampton Cancer Research UK Centre.

Professor Mark Cragg
Professor in Experimental Cancer Biology

Mark is a world-leading cancer immunologist who researches how the body’s immune cells develop new ways to overcome resistance to immunotherapy.

Related case studies

SUPPORT the future of medicine

By donating to the Institute for Medical Innovation you can help save the life of someone with cancer. You can help us create a space where the best people work together to achieve incredible results. Your donation will accelerate research and bring tomorrow’s cures, today. 

We need to raise £50m to build this incredible facility. Join us and be at the heart of medical innovation.